Direct haemodynamic effects of pulmonary arteriovenous malformation embolisation
Open Access
- 7 March 2014
- journal article
- research article
- Published by Springer Nature in Netherlands Heart Journal
- Vol. 22 (7) , 328-333
Abstract
Background Transcatheter embolisation is widely used to close pulmonary arteriovenous malformations (PAVMs) in patients with hereditary haemorrhagic telangiectasia (HHT). Data on the direct cardiovascular haemodynamic changes induced by this treatment are scarce. Objectives We investigated the direct haemodynamic effects of transcatheter embolisation of PAVMs, using non-invasive finger pressure measurements. Methods During the procedure, blood pressure, heart rate (HR), stroke volume (SV), cardiac output (CO), total peripheral resistance (TPR) and delta pressure/delta time (dP/dt) were continuously monitored using a Finometer®. Potential changes in these haemodynamic parameters were calculated from the pressure registrations using Modelflow® methodology. Absolute and relative changes were calculated and compared using the paired sample t-test. Results The present study includes 29 HHT patients (mean age 39 ± 15 years, 11 men) who underwent transcatheter embolotherapy of PAVMs. The total number of embolisations was 72 (mean per patient 2.5). Directly after PAVM closure, SV and CO decreased significantly by −11.9 % (p = 0.01) and −9.5 % (p = 0.01) respectively, without a significant change in HR (1.8 %). Mean arterial blood pressure increased by 4.1 % (p = 0.02), while the TPR and dP/dt did not increase significantly (5.8 % and 0.2 %, respectively). Conclusions Significant haemodynamic changes occur directly after transcatheter embolisation of PAVMs, amongst which a decrease in stroke volume and cardiac output are most important.Keywords
This publication has 21 references indexed in Scilit:
- Haemodynamic effects of patent foramen ovale and atrial septal defect closure: a comparison during percutaneous shunt closureClinical Physiology and Functional Imaging, 2009
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasiaJournal of Medical Genetics, 2009
- Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAHEuropean Respiratory Review, 2009
- Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective studyEuropean Respiratory Journal, 2008
- Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressureEuropean Respiratory Journal, 2008
- The effect of temperature on systolic blood pressureBlood Pressure Monitoring, 2007
- Validation of the Finometer device for measurement of blood pressure in black womenJournal of Human Hypertension, 2004
- Haemodynamics and gas exchange before and after coil embolization of pulmonary arteriovenous malformationsEuropean Respiratory Journal, 1995
- Evaluation of the Penàz servo-plethysmo-manometer for the continuous, non-invasive measurement of finger blood pressureBasic Research in Cardiology, 1984